22 completed, 2 terminated, 2 unknown, 1 not yet recruiting. 9 Not applicable, 7 Phase 2, 4 Phase 3, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 9 | Completed 7, Terminated 1, Withdrawn 1 |
| Phase 2 | 7 | Completed 5, Unknown 2 |
| Phase 3 | 4 | Completed 3, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Keratosis, Seborrheic: new trials by email Literature Review of Keratosis, Seborrheic trials Research Report on Keratosis, Seborrheic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis Clinical decision support tool - Malignant Melanoma of Skin, Other and Unspecified Malignant Neoplasm of Skin | Phase 3 | Recruiting | Memorial Sloan Kettering Cancer Center | 14000 | 2026-10-15 | 2026-10-22 |
| AI in SK Histopathological Diagnosis This study doesn't include an intervention. - Seborrheic Keratoses, Artifical Intelligence | Not yet recruiting | Al-Azhar University | 30 | 2026-10-01 | 2026-08-26 | |
| Optimizing the Timing for Facial Surgical Dressing Removal sterile gauze dressing - Nevus, Seborrheic Keratosis (SK) | Not applicable | Completed | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 144 | 2025-06-15 | 2026-03-03 |
| Impact of Skin Type on Wonud Healing and Scarring Following Facial Skin Surgery Nevus, Seborrheic Keratosis (SK) | Completed | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 173 | 2025-06-15 | 2026-02-03 | |
| Effect of 1% Andaliman Fruit Extract Cream on Facial Seborrheic Keratosis 1% Andaliman Fruit Extract Cream - Seborrheic Keratosis | Not applicable | Completed | Universitas Sumatera Utara | 40 | 2025-01-01 | 2026-01-12 |
| Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists AI-based medical device for aided diagnosis in Dermatology - Pustular Psoriasis (PP), Generalized Pustular Psoriasis (GPP) | Completed | AI Labs Group S.L | 15 | 2024-06-01 | 2026-02-24 | |
| Using Artificial Intelligence to Help Doctors Identify Different Skin Conditions and Improve Patient Care AI-based medical device for aided diagnosis in Dermatology - Dermatitis, Melanoma (Skin Cancer) | Completed | AI Labs Group S.L | 16 | 2024-06-01 | 2026-02-24 | |
| A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis SM-020 gel 1.0%, Vehicle gel - Seborrheic Keratosis | Phase 2 | Unknown | DermBiont, Inc. | 60 | 2023-11-06 | 2024-05-10 |
| Relationship Between Serum Xanthine Oxidase Levels and Seborrheic Keratosis Serum Xanthine Oxidase Level Assessment - Seborrheic Keratosis (SK), Oxidative Stress | Completed | Sri Nauli Dewi Lubis | 80 | 2023-10-01 | 2025-07-31 | |
| Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented Tumors Fluorescence-Advanced videodermatoscopy, Reflectance confocal microscopy, Super-high magnification dermoscopy - Basal Cell Carcinoma, Lentigo Maligna | Completed | Centre Hospitalier Universitaire de Saint Etienne | 161 | 2022-11-02 | 2024-06-24 | |
| Adaptive Design Study for Safety and Efficacy of Treatment Regimens With SM-020 in Subjects With Seborrheic Keratosis SM-020 - Seborrheic Keratosis | Phase 2 | Unknown | DermBiont, Inc. | 70 | 2021-10-19 | 2023-10-03 |
| Effectiveness of Sodium Fusidate Ointment Compared to Petrolatum for Wound Healing Following Cauterization Sodium Fusidate 2 % Topical Ointment, Petrolatum ointment - Seborrheic Keratosis, Acrochordon | Not applicable | Completed | Universitas Indonesia | 22 | 2021-01-01 | 2022-05-05 |
| Fast Track Diagnosis of Skin Cancer by Advanced Imaging optical coherence tomography - Malignant Melanoma, Nevus, Pigmented | Not applicable | Completed | University Hospital Bispebjerg and Frederiksberg | 41 | 2019-09-09 | 2024-06-20 |
| Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage Electrical Impedence Spectroscopy DermaSense - Melanoma (Skin), Basal Cell Carcinoma | Terminated | Aristotle University Of Thessaloniki | 50 | 2019-07-17 | 2023-07-25 | |
| Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Optimization Study Nano-Pulse Stimulation (NPS) - Lesion Skin, Seborrheic Keratosis | Not applicable | Terminated | Pulse Biosciences, Inc. | 175 | 2019-02-05 | 2023-10-30 |
| An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses A-101 Topical Solution - Seborrheic Keratosis | Phase 4 | Completed | Aclaris Therapeutics, Inc. | 41 | 2018-03-21 | 2019-10-02 |
| A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic Keratosis A-101 - Seborrheic Keratosis | Phase 2 | Completed | Aclaris Therapeutics, Inc. | 253 | 2017-05-17 | 2019-05-06 |
| Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Study Nano-Pulse Stimulation (NPS) - Lesion Skin, Seborrheic Keratosis | Not applicable | Completed | Pulse Biosciences, Inc. | 58 | 2017-05-04 | 2023-08-22 |
| A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis. A-101 Solution, Vehicle Solution - Seborrheic Keratosis | Phase 3 | Completed | Aclaris Therapeutics, Inc. | 450 | 2016-01-01 | 2018-02-06 |
| A Randomized, Double-Blind, Vehicle-Controlled Study in Subjects With Seborrheic Keratosis A-101 Solution, Vehicle Solution - Seborrheic Keratosis | Phase 3 | Completed | Aclaris Therapeutics, Inc. | 487 | 2016-01-01 | 2018-02-06 |
Showing 20 of 29. Sign in to see all of them.
Melanoma (6) · Nevus (5) · Carcinoma, Basal Cell (4) · Acne Vulgaris (2) · Carcinoma, Squamous Cell (2) · Cicatrix (2) · Cysts (2) · Dysplastic Nevus Syndrome (2) · Hemangioma (2) · Hutchinson's Melanotic Freckle (2) · Lipoma (2) · Nevus, Pigmented (2) · Psoriasis (2) · Skin Diseases (2)
Keratosis (29) · Skin and Connective Tissue Diseases (29) · Skin Diseases (27) · Neoplasms (8) · Neoplasms by Histologic Type (8) · Nevi and Melanomas (8) · Neoplasms by Site (6) · Neoplasms, Germ Cell and Embryonal (6) · Neoplasms, Nerve Tissue (6) · Neuroectodermal Tumors (6) · Neuroendocrine Tumors (6) · Skin Neoplasms (6) · Carcinoma (4) · Neoplasms, Basal Cell (4) · Neoplasms, Connective and Soft Tissue (4)
N-phenylacetoaminomethylene-DL-p-nitrophenylalanine (4) · Curettage (2) · 3-ingenyl angelate (1) · Cryosurgery (1) · Fusidic Acid (1) · Gels (1) · Lasers, Dye (1) · Ointments (1) · Solutions (1) · Tomography, Optical Coherence (1) · Ultrasonography, Doppler (1)
Aclaris Therapeutics, Inc. (8) · AI Labs Group S.L (2) · DermBiont, Inc. (2) · Pulse Biosciences, Inc. (2) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (2) · Al-Azhar University (1) · Aristotle University Of Thessaloniki (1) · Centre Hospitalier Universitaire de Saint Etienne (1) · Memorial Sloan Kettering Cancer Center (1) · Milton S. Hershey Medical Center (1) · Northwestern University (1) · Peplin (1) · Sri Nauli Dewi Lubis (1) · Universitas Indonesia (1) · Universitas Sumatera Utara (1)
United States (15) · Indonesia (3) · China (2) · Spain (2) · Australia (1) · Denmark (1) · Egypt (1) · El Salvador (1) · France (1) · Greece (1)
Stuart D Shanler, MD (4) · Antonio Martorell, PhD (2) · Janet Dubois, MD (2) · Richard A Nuccitelli, PhD (2) · Andrew Blauvelt, MD, MBA (1) · Brian Beger, BS (1) · Daniel Eisen, M.D. (1) · Daniel M Stewart, DO (1) · David C Wilson, MD (1) · David Gordon, MD (1) · David Zepeda, MD (1) · Emmanouil Papanastasiou, Dr. (1) · Firman Parrol, MD (1) · Imam Budi Putra, MD (1)
R01CA293974 (1)